Session Details
[1PS-05]【J】Integrated understanding of disease pathogenesis based on interstitial cell diversity.
Wed. Nov 27, 2024 4:45 PM - 7:00 PM JST
Wed. Nov 27, 2024 7:45 AM - 10:00 AM UTC
Wed. Nov 27, 2024 7:45 AM - 10:00 AM UTC
Room 5(Fukuoka International Congress Center, 4F 409+410)
Organizer: Takashi Satoh (Institute of Science Tokyo), Hisamichi Naito (Kanazawa University)
Co-hosted by: Grant-in-Aid for Scientific Research on Innovative Areas B, Interstitial literacy
In disease onset and progression, we have primarily studied the parenchyma of organs. On the other hand, the term "interstitium" has conventionally indicated the "location" where pathologies arise from various causes. In addition, the specificity of the interstitial response in individual organs and diseases is not well understood at all. In recent years, however, the necessity of studying cells in the interstitium has begun to be recognized. Therefore, the goal of this symposium is to study the interstitium from various angles and redefine its meaning.
Introduction
[1PS-05-01]Tertiary lymphoid structure, an inflammatory microenvironment in the kidney interstitium
○Motoko Yanagita1 (1. Kyoto University)
[1PS-05-02]Heart failure-induced stress memory reduces macrophage diversity and leads to multimorbidity
○Ichiro Manabe1 (1. Chiba University)
[1PS-05-03]Toward a comprehensive understanding of interstitial intercellular crosstalk in the pathogenesis of central nervous system diseases.
○Takahiro Masuda1 (1. Kyushu University)
[1PS-05-04]Neuronal regulation of immunometabolism in liver
○Takayoshi SUGANAMI1 (1. Nagoya Univ., RIeM)
[1PS-05-05(1P-958)]Comprehensive single-cell analysis of stromal cells in liver fibrosis resolution
○Eiko Saijou1, Luis AE Nagai1, Tohru Itoh2, Naoko Yokota1, Ryuichiro Nakato1 (1. Computational Genomics, IQB, Univ. Tokyo, 2. Research Core, Institute of Research, TMDU)
[1PS-05-06(1P-863)]SIGLEC7 in NK cells is an immune checkpoint receptor for VSIG4
○Yutaka Kasai1,2, Yuki Azuma2, Mai Mizusawa2, Yota Mitobe2, Miko Komiya1,2, Yumi Tsuboi2, Takeshi Ito3,2, Yoshinori Murakami1,2 (1. Dept. Mol. Biol., Inst. Adv. Med. Sci., Nippon Med. Sch., 2. Div. Mol. Pathol., Inst. Med. Sci., Univ. Tokyo, 3. Sect. Med. Oncol., Dept. Intern. Med., Yale Sch. Med.)